<DOC>
	<DOCNO>NCT00300508</DOCNO>
	<brief_summary>The study assess effect 3 year adjuvant treatment anastrozole vs. untreated control group initial 5 year adjuvant hormone-therapy .</brief_summary>
	<brief_title>3 Years Anastrozole vs. Treatment Extended Adjuvant Therapy Postmenopausal Women With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>No disease recurrence time randomization , patient breast cancer surgery , 5 year ( +/ 12 month ) prior endocrine therapy Premenopausal patient , unknown negative receptor status , Secondary malignant tumor</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Hormone receptor positive breast cancer</keyword>
</DOC>